Cargando…

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

Detalles Bibliográficos
Autores principales:	Lerche, Stefanie, Heinzel, Sebastian, Alves, Guido W., Barone, Paolo, Behnke, Stefanie, Ben-Shlomo, Yoav, Berendse, Henk, Bloem, Bastiaan R., Burn, David, Dodel, Richard, Grosset, Donald G., Hipp, Geraldine, Hu, Michele T., Kasten, Meike, Krüger, Rejko, Liepelt-Scarfone, Inga, Maetzler, Walter, Moccia, Marcello, Mollenhauer, Brit, Oertel, Wolfgang, Roeben, Benjamin, Walter, Uwe, Wirdefeldt, Karin, Berg, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882324/ https://www.ncbi.nlm.nih.gov/pubmed/27303289 http://dx.doi.org/10.3389/fnagi.2016.00121

Ejemplares similares

Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
por: Heinzel, Sebastian, et al.
Publicado: (2016)

Validation of conversion between mini–mental state examination and montreal cognitive assessment
por: Lawton, Michael, et al.
Publicado: (2016)

Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease
por: Yilmaz, Rezzak, et al.
Publicado: (2016)

A Neurodegenerative Vascular Burden Index and the Impact on Cognition
por: Heinzel, Sebastian, et al.
Publicado: (2014)

Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014)

Post-Cueing Deficits with Maintained Cueing Benefits in Patients with Parkinson’s Disease Dementia
por: Gräber, Susanne, et al.
Publicado: (2014)

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease
por: Schaeffer, Eva, et al.
Publicado: (2019)

Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2021)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire
por: Becker, Sara, et al.
Publicado: (2021)

Clinical Characteristics with an Impact on ADL Functions of PD Patients with Cognitive Impairment Indicative of Dementia
por: Liepelt-Scarfone, Inga, et al.
Publicado: (2013)

Influence of Different Cut-Off Values on the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease
por: Liepelt-Scarfone, Inga, et al.
Publicado: (2011)

Effect of Fear of Falling on Mobility Measured During Lab and Daily Activity Assessments in Parkinson’s Disease
por: Atrsaei, Arash, et al.
Publicado: (2021)

Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study
por: Leplow, Bernd, et al.
Publicado: (2023)

Instrumented Functional Reach Test Differentiates Individuals at High Risk for Parkinson’s Disease from Controls
por: Hasmann, Sandra E., et al.
Publicado: (2014)

Management of Parkinson’s Disease 20 Years from Now: Towards Digital Health Pathways
por: Klucken, Jochen, et al.
Publicado: (2018)

No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson’s disease
por: Bettecken, Kristina, et al.
Publicado: (2017)

Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
por: Bernhard, Felix P., et al.
Publicado: (2016)

Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
por: Haertner, Linda, et al.
Publicado: (2018)

Mild Parkinsonian Signs in the Elderly – Is There an Association with PD? Crossectional Findings in 992 Individuals
por: Lerche, Stefanie, et al.
Publicado: (2014)

Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease
por: Maetzler, Walter, et al.
Publicado: (2012)

Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson’s Disease
por: Tkaczynska, Zuzanna, et al.
Publicado: (2020)

Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study
por: Becker, Sara, et al.
Publicado: (2022)

The elephant in the room: critical reflections on mortality rates among individuals with Parkinson’s disease
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2023)

Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)

CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
por: Lerche, Stefanie, et al.
Publicado: (2022)

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
por: Lerche, Stefanie, et al.
Publicado: (2023)

Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
por: Hobert, Markus A., et al.
Publicado: (2019)

Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting
por: Bowring, Francesca, et al.
Publicado: (2022)

Determinants of coping styles of people with Parkinson’s Disease
por: Prins, Eva M., et al.
Publicado: (2023)

Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
por: Mielke, Michelle M., et al.
Publicado: (2013)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Biomarkers in biological fluids for dementia with Lewy bodies
por: Schade, Sebastian, et al.
Publicado: (2014)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
por: Malek, Naveed, et al.
Publicado: (2017)

Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study
por: Gorges, Martin, et al.
Publicado: (2019)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Comparison between four published definitions of hyposmia in Parkinson's disease
por: Kanavou, Sofia, et al.
Publicado: (2021)

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
por: Maetzler, Walter, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lc8pp83hm9jj32bs06procn44c